Related content

Recruitment of dendritic cells and enhanced antigen-specific immune reactivity in cancer patients treated with hr-GM-CSF (Molgramostim) and hr-IL-2 - results from a phase Ib clinical trial

By Correale P.   Campoccia G.   Tsang K.Y.   Micheli L.   Cusi M.G.   Sabatino M.   Bruni G.   Sestini S.   Petrioli R.   Pozzessere D.   Marsili S.   Fanetti G.   Giorgi G.   Francini G.  

European Journal of Cancer, Vol. 37, Iss. 7, 2001-05 ,pp. : 892-902

Elsevier

Access to resources Recommend Favorite

Properties of bcr-abl-transformed mouse 12B1 cells secreting interleukin-2 and granulocyte-macrophage colony stimulating factor (GM-CSF): II. Adverse effects of GM-CSF

By          

International Journal of Oncology, Vol. 40, Iss. 6, 2012-01 ,pp. : 1915-1922

Spandidos Publications

Access to resources Recommend Favorite

Highly metastatic variant of a mouse colon carcinoma cell line, LM17 and its response to GM-CSF gene therapy

By Ikubo Akashi   Aoki Yasuaki   Nagai Eishi   Suzuki Tsuneo  

Clinical and Experimental Metastasis, Vol. 17, Iss. 10, 1999-12 ,pp. : 849-855

Springer Publishing Company

Access to resources Recommend Favorite

Enhanced anti-tumor immunity ex vivo induced by GM-CSF gene transducted dendritic cell vaccine

By He Songbing   Wang Liang   Sun Kang   Zhang Yanyun   Li Dechun  

The Chinese-German Journal of Clinical Oncology, Vol. 10, Iss. 3, 2011-03 ,pp. : 178-182

Springer Publishing Company

Access to resources Recommend Favorite

Addition of GM-CSF to a peptide/KLH vaccine results in increased frequencies of CXCR3-expressing KLH-specific T cells

By Na Il-Kang   Keilholz Ulrich   Letsch Anne   Bauer Sandra   Asemissen Anne   Nagorsen Dirk   Thiel Eckhard   Scheibenbogen Carmen  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 3, 2007-03 ,pp. : 391-396

Springer Publishing Company

Access to resources Recommend Favorite